• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组 XV 磷脂酶 A₂,溶酶体磷脂酶 A₂。

Group XV phospholipase A₂, a lysosomal phospholipase A₂.

机构信息

Nephrology Division, Department of Internal Medicine, University of Michigan, USA.

出版信息

Prog Lipid Res. 2011 Jan;50(1):1-13. doi: 10.1016/j.plipres.2010.10.006. Epub 2010 Nov 11.

DOI:10.1016/j.plipres.2010.10.006
PMID:21074554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3039127/
Abstract

A phospholipase A₂ was identified from MDCK cell homogenates with broad specificity toward glycerophospholipids including phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and phosphatidylglycerol. The phospholipase has the unique ability to transacylate short chain ceramides. This phospholipase is calcium-independent, localized to lysosomes, and has an acidic pH optimum. The enzyme was purified from bovine brain and found to be a water-soluble glycoprotein consisting of a single peptide chain with a molecular weight of 45 kDa. The primary structure deduced from the DNA sequences is highly conserved between chordates. The enzyme was named lysosomal phospholipase A₂ (LPLA₂) and subsequently designated group XV phospholipase A₂. LPLA₂ has 49% of amino acid sequence identity to lecithin-cholesterol acyltransferase and is a member of the αβ-hydrolase superfamily. LPLA₂ is highly expressed in alveolar macrophages. A marked accumulation of glycerophospholipids and extensive lamellar inclusion bodies, a hallmark of cellular phospholipidosis, is observed in alveolar macrophages in LPLA₂(-/-) mice. This defect can also be reproduced in macrophages that are exposed to cationic amphiphilic drugs such as amiodarone. In addition, older LPLA₂(-/-) mice develop a phenotype similar to human autoimmune disease. These observations indicate that LPLA₂ may play a primary role in phospholipid homeostasis, drug toxicity, and host defense.

摘要

一种具有广泛甘油磷脂特异性的磷脂酶 A₂从 MDCK 细胞匀浆中被鉴定出来,包括磷脂酰胆碱、磷脂酰乙醇胺、磷脂酰丝氨酸和磷脂酰甘油。该磷脂酶具有将短链神经酰胺转酰基化的独特能力。这种磷脂酶是钙离子非依赖性的,定位于溶酶体中,具有酸性 pH 最佳值。该酶从牛脑中纯化出来,发现是一种水溶性糖蛋白,由一条分子量为 45 kDa 的单一肽链组成。从 DNA 序列推导出来的一级结构在脊索动物之间高度保守。该酶被命名为溶酶体磷脂酶 A₂(LPLA₂),随后被指定为 XV 组磷脂酶 A₂。LPLA₂与卵磷脂-胆固醇酰基转移酶有 49%的氨基酸序列同一性,是 αβ-水解酶超家族的成员。LPLA₂在肺泡巨噬细胞中高度表达。在 LPLA₂(-/-) 小鼠的肺泡巨噬细胞中观察到甘油磷脂的明显积累和广泛的板层包涵体,这是细胞磷脂沉积的标志。这种缺陷也可以在暴露于阳离子两亲性药物(如胺碘酮)的巨噬细胞中重现。此外,年老的 LPLA₂(-/-) 小鼠会出现类似于人类自身免疫性疾病的表型。这些观察结果表明,LPLA₂可能在磷脂稳态、药物毒性和宿主防御中发挥主要作用。

相似文献

1
Group XV phospholipase A₂, a lysosomal phospholipase A₂.组 XV 磷脂酶 A₂,溶酶体磷脂酶 A₂。
Prog Lipid Res. 2011 Jan;50(1):1-13. doi: 10.1016/j.plipres.2010.10.006. Epub 2010 Nov 11.
2
The secretion and uptake of lysosomal phospholipase A2 by alveolar macrophages.肺泡巨噬细胞对溶酶体磷脂酶A2的分泌与摄取
J Immunol. 2008 Dec 1;181(11):7873-81. doi: 10.4049/jimmunol.181.11.7873.
3
Cloning and characterization of a lysosomal phospholipase A2, 1-O-acylceramide synthase.一种溶酶体磷脂酶A2(1-O-酰基神经酰胺合酶)的克隆与特性分析
J Biol Chem. 2002 Mar 22;277(12):10090-9. doi: 10.1074/jbc.M111977200. Epub 2002 Jan 14.
4
A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity.道路的转折:关于葡萄糖神经酰胺合酶抑制剂药理学的研究如何促成了具有神经酰胺转酰基酶活性的溶酶体磷脂酶A2的发现。
Glycoconj J. 2004;20(1):25-32. doi: 10.1023/B:GLYC.0000016739.32089.55.
5
Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis.抑制溶酶体磷脂酶 A2 可预测药物诱导的磷脂沉积症。
J Lipid Res. 2021;62:100089. doi: 10.1016/j.jlr.2021.100089. Epub 2021 Jun 1.
6
Lysosomal phospholipase A2 and phospholipidosis.溶酶体磷脂酶A2与磷脂沉积症
Mol Cell Biol. 2006 Aug;26(16):6139-48. doi: 10.1128/MCB.00627-06.
7
Lysosomal phosphatidylcholine: bis(monoacylglycero)phosphate acyltransferase: specificity for the sn-1 fatty acid of the donor and co-purification with phospholipase A1.溶酶体磷脂酰胆碱:双(单酰甘油)磷酸酯酰基转移酶:对供体sn-1脂肪酸的特异性以及与磷脂酶A1的共纯化
Biochim Biophys Acta. 1993 Apr 7;1167(2):204-10. doi: 10.1016/0005-2760(93)90163-4.
8
Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.溶酶体磷脂酶A2和卵磷脂:胆固醇酰基转移酶的结构与功能
Nat Commun. 2015 Mar 2;6:6250. doi: 10.1038/ncomms7250.
9
Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages.溶酶体磷脂酶A2在肺泡巨噬细胞中选择性表达。
J Biol Chem. 2004 Oct 8;279(41):42605-11. doi: 10.1074/jbc.M407834200. Epub 2004 Aug 4.
10
The role of lysosomal phospholipase A2 in the catabolism of bis(monoacylglycerol)phosphate and association with phospholipidosis.溶酶体磷脂酶 A2 在双(单酰基甘油)磷酸酯分解代谢中的作用及其与磷脂蓄积的关系。
J Lipid Res. 2024 Jul;65(7):100574. doi: 10.1016/j.jlr.2024.100574. Epub 2024 Jun 9.

引用本文的文献

1
Degradation of oxidized phospholipids by lysosomal phospholipase A2 regulates pulmonary fibrosis.溶酶体磷脂酶A2对氧化磷脂的降解调控肺纤维化。
Am J Physiol Lung Cell Mol Physiol. 2025 Aug 1;329(2):L214-L223. doi: 10.1152/ajplung.00038.2025. Epub 2025 Jun 26.
2
RNAi screening of uncharacterized genes identifies promising druggable targets in Schistosoma japonicum.对未鉴定基因进行RNA干扰筛选可识别日本血吸虫中有前景的可成药靶点。
PLoS Pathog. 2025 Mar 28;21(3):e1013014. doi: 10.1371/journal.ppat.1013014. eCollection 2025 Mar.
3
Polysorbates degrading enzymes in biotherapeutics - a current status and future perspectives.生物治疗药物中的聚山梨酯降解酶——现状与未来展望
Front Bioeng Biotechnol. 2025 Jan 10;12:1490276. doi: 10.3389/fbioe.2024.1490276. eCollection 2024.
4
PLD3 and PLD4 synthesize S,S-BMP, a key phospholipid enabling lipid degradation in lysosomes.PLD3 和 PLD4 合成 S,S-BMP,一种关键的磷脂,可使溶酶体中的脂质降解。
Cell. 2024 Nov 27;187(24):6820-6834.e24. doi: 10.1016/j.cell.2024.09.036. Epub 2024 Oct 17.
5
Molecular determinants of phospholipid treatment to reduce intracellular cholesterol accumulation in NPC1 deficiency.磷脂治疗减少NPC1缺乏症细胞内胆固醇积累的分子决定因素。
J Biol Chem. 2024 Nov;300(11):107889. doi: 10.1016/j.jbc.2024.107889. Epub 2024 Oct 11.
6
PLD3 and PLD4 synthesize -BMP, a key phospholipid enabling lipid degradation in lysosomes.PLD3和PLD4合成β-溶血磷脂酸,这是一种关键的磷脂,可促进溶酶体中的脂质降解。
bioRxiv. 2024 Mar 21:2024.03.21.586175. doi: 10.1101/2024.03.21.586175.
7
Integrated Analysis of the Intestinal Microbiota and Transcriptome of Response to Low-Salinity Stress.低盐度胁迫响应中肠道微生物群与转录组的综合分析
Biology (Basel). 2023 Dec 7;12(12):1502. doi: 10.3390/biology12121502.
8
Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease.颗粒蛋白前体和 GPNMB:神经退行性疾病中内溶酶体功能和炎症的相互作用。
J Neuroinflammation. 2023 Nov 30;20(1):286. doi: 10.1186/s12974-023-02965-w.
9
Lysosomal phospholipase A2 contributes to the biosynthesis of the atypical late endosome lipid bis(monoacylglycero)phosphate.溶酶体磷脂酶 A2 有助于非典型晚期内涵体脂质双(单酰基甘油)磷酸的生物合成。
Commun Biol. 2023 Feb 23;6(1):210. doi: 10.1038/s42003-023-04573-z.
10
Positive Correlation of Triacylglycerols with Increased Chain Length and Unsaturation with ω-O-Acylceramide and Ceramide-NP as Well as Acidic pH in the Skin Surface of Healthy Korean Adults.韩国健康成年人皮肤表面三酰甘油与链长增加及不饱和度增加与ω-O-酰基神经酰胺和神经酰胺-NP的正相关以及酸性pH值的关系
Metabolites. 2022 Dec 24;13(1):31. doi: 10.3390/metabo13010031.

本文引用的文献

1
Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study.口服伊米苷酶(Genz-112638)治疗戈谢病 1 型:2 年 2 期研究的血液学、内脏和骨骼表现改善结果。
Blood. 2010 Nov 18;116(20):4095-8. doi: 10.1182/blood-2010-06-293902. Epub 2010 Aug 16.
2
A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.一项关于伊曲康唑(Genz-112638)的 2 期研究,这是一种用于治疗 1 型戈谢病的口服底物减少疗法。
Blood. 2010 Aug 12;116(6):893-9. doi: 10.1182/blood-2010-03-273151. Epub 2010 May 3.
3
Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.酸性鞘磷脂酶、细胞膜与人类疾病:尼曼-匹克病的启示。
FEBS Lett. 2010 May 3;584(9):1895-900. doi: 10.1016/j.febslet.2009.11.083. Epub 2009 Nov 26.
4
Identification of the amino acid sequence that targets peroxiredoxin 6 to lysosome-like structures of lung epithelial cells.确定将过氧化物酶体增殖物激活受体6靶向肺上皮细胞溶酶体样结构的氨基酸序列。
Am J Physiol Lung Cell Mol Physiol. 2009 Nov;297(5):L871-80. doi: 10.1152/ajplung.00052.2009. Epub 2009 Aug 21.
5
Lysosomes as "suicide bags" in cell death: myth or reality?溶酶体作为细胞死亡中的“自杀袋”:神话还是现实?
J Biol Chem. 2009 Aug 14;284(33):21783-21787. doi: 10.1074/jbc.R109.023820. Epub 2009 May 27.
6
A role for lysosomal phospholipase A2 in drug induced phospholipidosis.溶酶体磷脂酶A2在药物诱导的磷脂沉积症中的作用。
Drug Metab Lett. 2007 Jan;1(1):49-53. doi: 10.2174/187231207779814292.
7
The role of negatively charged lipids in lysosomal phospholipase A2 function. negatively charged lipids 在溶酶体磷脂酶 A2 功能中的作用。
J Lipid Res. 2009 Oct;50(10):2027-35. doi: 10.1194/jlr.M900008-JLR200. Epub 2009 Mar 25.
8
The secretion and uptake of lysosomal phospholipase A2 by alveolar macrophages.肺泡巨噬细胞对溶酶体磷脂酶A2的分泌与摄取
J Immunol. 2008 Dec 1;181(11):7873-81. doi: 10.4049/jimmunol.181.11.7873.
9
Bioactive sphingolipids: metabolism and function.生物活性鞘脂:代谢与功能
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S91-6. doi: 10.1194/jlr.R800080-JLR200. Epub 2008 Nov 17.
10
Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation.溶酶体膜降解的原理:溶酶体脂质降解的细胞拓扑结构与生物化学
Biochim Biophys Acta. 2009 Apr;1793(4):674-83. doi: 10.1016/j.bbamcr.2008.09.020. Epub 2008 Nov 1.